Company Overview of Diacrin, Inc.
As of August 21, 2003, Diacrin, Inc. was acquired by GenVec, Inc. Previously, Diacrin, Inc. focused on developing cell transplantation technology for treating human diseases that were characterized by cell dysfunction or cell death, and for which current therapies were either inadequate or nonexistent. The company was founded in 1989 and had principal executive offices in Charlestown, Massachusetts.
Building 96 13th Street
Charlestown Navy Yard
Charlestown, MA 02129
Key Executives for Diacrin, Inc.
Diacrin, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|GreenLeaf Genetics, LLC||United States|
|Aspira Biosystems, Inc.||United States|
|Abraxis Bioscience International Holding Co., Inc.||United States|
|Pyramid Biological Corporation||United States|
|QRS Heart, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Diacrin, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.